Edward Flotte, MD
Neurological Surgery · Mobile, ALNPI 1780673814
Payments from drug & device makers
Across 34 payments — averaging $21.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz Pharmaceuticals, LLC$82
- AstraZeneca$80
- Acadia Pharmaceuticals Inc$77
- Novartis$46
- Providence Medical Technology, Inc.$46
- AbbVie$46
- plus $360 from 13 others
What the payments were for
- Food & beverage$736100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz Pharmaceuticals, LLC | 3 | $82 |
| AstraZeneca | 3 | $80 |
| Acadia Pharmaceuticals Inc | 3 | $77 |
| Novartis | 3 | $46 |
| Providence Medical Technology, Inc. | 1 | $46 |
| AbbVie | 2 | $46 |
| UCB, Inc. | 2 | $45 |
| Medtronic | 3 | $42 |
| EMD Serono, Inc. | 2 | $41 |
| Tanabe Pharma America, Inc. | 2 | $37 |
| Argenx US, Inc. | 1 | $31 |
| Sandoz | 1 | $31 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Grifols USA, LLC | 1 | $24 |
| SK Life Science, Inc. | 1 | $23 |
| Silk Road Medical, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$736 in reported general payments places this provider in the 25th percentile of 97 neurological surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 158 | $2,171 |
| Methylprednisolone | 31 | $270 |
| Cyclobenzaprine Hcl | 28 | $140 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $81 |
| Tramadol Hcl | 16 | $79 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Mobile
- Richard MengerMobile$249K
- Amber GordonMobile$24K
- Andrew RomeoMobile$12K
- William FairclothMobile$6K
- Anthony MartinoMobile$6K
- John AmburgyMobile$5K
- Donald TylerMobile$5K
- Shawn ClarkMobile$4K
- Marc ManixMobile$3K
- Nidal OmarMobile$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.